Studies Nieuws Nieuwsbrief Over ons Archief
Zoek beschikbare studies

Studieoverzicht

Study name: TIGER Meso

Histology Mesothelioma
Tumor stage Stage IV
Host / recruiting sites Erasmus MC
Enrollment Recruiting
Therapy line First line (1L)
Design

Non-interventional, observational, prospective, multicentre study on a marketed medical device used in routine clinical care settings following its Instruction For Use within in the approved population
Intervention

TTFields in general routine clinical care in patients with pleural mesothelioma study
Key inclusion criteria
  • Histologically confirmed pleural mesothelioma without any option of curative resection
  • Life expectancy more than 3 months at day of enrollment
Key exclusion criteria
  • Previous treatment with NovoTTF-200T for more than 1 week at day of enrollment
Contact information